- Home
- IVP vs XYLO Comparison
IVP vs XYLO Comparison
Compare IVP & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- XYLO
- Stock Information
- Founded
- IVP 2020
- XYLO 1999
- Country
- IVP United States
- XYLO Israel
- Employees
- IVP N/A
- XYLO N/A
- Industry
- IVP Diversified Commercial Services
- XYLO
- Sector
- IVP Miscellaneous
- XYLO
- Exchange
- IVP Nasdaq
- XYLO NYSE
- Market Cap
- IVP 3.3M
- XYLO 3.8M
- IPO Year
- IVP 2023
- XYLO N/A
- Fundamental
- Price
- IVP $1.71
- XYLO $4.84
- Analyst Decision
- IVP
- XYLO
- Analyst Count
- IVP 0
- XYLO 0
- Target Price
- IVP N/A
- XYLO N/A
- AVG Volume (30 Days)
- IVP 82.0K
- XYLO 1.5K
- Earning Date
- IVP 06-17-2025
- XYLO 06-17-2025
- Dividend Yield
- IVP N/A
- XYLO N/A
- EPS Growth
- IVP N/A
- XYLO N/A
- EPS
- IVP N/A
- XYLO N/A
- Revenue
- IVP $15,399,751.00
- XYLO $29,858,000.00
- Revenue This Year
- IVP N/A
- XYLO $279.19
- Revenue Next Year
- IVP N/A
- XYLO N/A
- P/E Ratio
- IVP N/A
- XYLO N/A
- Revenue Growth
- IVP N/A
- XYLO N/A
- 52 Week Low
- IVP $1.26
- XYLO $2.70
- 52 Week High
- IVP $401.50
- XYLO $6.67
- Technical
- Relative Strength Index (RSI)
- IVP 55.50
- XYLO 41.82
- Support Level
- IVP $1.62
- XYLO $4.79
- Resistance Level
- IVP $1.84
- XYLO $5.26
- Average True Range (ATR)
- IVP 0.16
- XYLO 0.12
- MACD
- IVP 0.01
- XYLO -0.04
- Stochastic Oscillator
- IVP 55.96
- XYLO 10.20
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About XYLO XYLO TECHNOLOGIES LTD
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.